SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,108 Cr | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,108 Cr |
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,108 Cr | Positive | |
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,472.2 Cr | 0.9% | -6.8% | 35.5% | Stock Analytics | |
| PRIME FOCUS | ₹22,004.3 Cr | 5.1% | -1% | 88.3% | Stock Analytics | |
| SAGILITY | ₹19,951.8 Cr | 0.9% | 3.5% | -6.5% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,959.1 Cr | -1.5% | -2.7% | -39.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,509.8 Cr | -3% | -3.8% | 0.6% | Stock Analytics | |
| INDEGENE | ₹13,636.2 Cr | 2% | 14.6% | -1.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 0.9% |
-6.8% |
35.5% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses